←Back to Expert Scholars
Translational Medicine / 转化医学Emerging Lung Targets
Oladimeji Adejumo
MD, PhD
🏢University of Maryland Greenebaum Cancer Center🌐USA
Assistant Professor of Oncology
22
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Oladimeji Adejumo focuses on translating emerging lung cancer targets into clinical practice with attention to equitable access. His work examines real-world implementation of HER2, MET and HER3 directed therapies. He also studies disparities in biomarker testing across patient populations.
Share:
🧪Research Fields 研究领域
Thoracic oncology
Health disparities
Targeted therapy access
Translational biomarkers
Clinical trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Oladimeji Adejumo 的研究动态
Follow Oladimeji Adejumo's research updates
留下邮箱，当我们发布与 Oladimeji Adejumo（University of Maryland Greenebaum Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment